POLICYBZRNSEPB Fintech LimitedMediumNeutral
Announced Thu, 22 May, 2025 · 18:12 IST

PB Fintech Limited has informed the Exchange about Transcript of Earnings Call

Mgmt Guided Margin ImprovementPromoter Disclosed Acquisition PlansInvestor Communications View source PDFExplain this filing

POLICYBZR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.4%1-day move
₹1762.00
prior close
₹1750.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.7+0.8+0.7+0.7+1.4+0.5-0.9+1.1-0.6-1.2+7.5+7.8+3.5+7.7
Up moveDown movePending
AI summary

PB Fintech (parent of Policybazaar and Paisabazaar) reported Q4 FY25 consolidated operating revenue of ₹1,508 Cr, up 38% YoY, with full-year revenue at ₹4,977 Cr (up 45% YoY). Insurance premium grew 37% YoY to ₹7,030 Cr in Q4, with the health segment continuing to grow at 4-5x the industry rate. Profit after tax jumped from ₹64 Cr to ₹353 Cr, and full-year PAT margin expanded from 2% to 7%. Core business EBITDA margin stood at 16% for the year, while new initiatives improved from -12% to -6%. Trail revenue reached ₹817 Cr (up 42% YoY) and the company holds ₹5,400 Cr in cash. Credit revenue was soft at ₹115 Cr (down 21% YoY core) and the savings business is currently challenged, though management plans to revive it through pensions and other products. Management guided to a 30% long-term CAGR and disclosed plans to acquire 2-3 operating hospitals and a few shell hospitals in NCR for its healthcare venture.

Likely market impact

Sustained margin expansion and on-plan delivery reinforce management credibility, which is positive for the stock. Near-term softness in savings and credit businesses, along with working capital pressure from 1/n accounting, are watchpoints, but improving core profitability and healthcare diversification support a constructive medium-term outlook.